Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial - Folegatti, PM; Harrison, K; Lopez, KR; Tilley, MW; Lopez-Camacho, C; Kim, YC; Preciado-Llanes, L; Rossi, SL; Poulton, I; Jenkin, D; Datoo, M; Themistocleous, Y; et al. (American Journal of Tropical Medicine and Hygiene, 2019)